Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Acq. announced Director departure Merger agrmnt [a] Appointed director
|
VYNE Therapeutics Inc. (MNLO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/21/2021 |
3
| Zeronda Tyler (Interim CFO) has filed a Form 3 on VYNE Therapeutics Inc. |
09/14/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/11/2020 |
3
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 3 on Menlo Therapeutics Inc. |
03/24/2020 |
3
| Saik Andrew (CFO) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/11/2020 |
3
| Stuart Iain (Chief Scientific Officer) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Hirsch Stanley (Director) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Harsch Mutya (Chief Legal Officer and GC) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Hadar Ilan (CFO and Country Manager) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Domzalski David (President and CEO) has filed a Form 3 on Menlo Therapeutics Inc. |
03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/21/2019 |
3
| Sandoval Elisabeth (Director) has filed a Form 3 on Menlo Therapeutics Inc. |
05/09/2018 |
3
| Spellman Mary (Chief Medical Officer) has filed a Form 3 on Menlo Therapeutics Inc. |
01/24/2018 |
3
| FMR LLC (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Merck & Co., Inc. (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Remeditex Ventures LLC (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Presidio Partners 2007 GP, L.P. (10% Owner) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Kwon Paul (Chief Medical Officer) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| BALL KRISTINE M (See Remarks) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| BERNS PAUL L (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Whitcup Scott M (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Cha Albert (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Royston Aaron (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| MCGIRR DAVID W J (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Ebel Ted (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
01/24/2018 |
3
| Basta Steven L (CEO) has filed a Form 3 on Menlo Therapeutics, Inc. |
|
|